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1. Introduction
1.1. Classification systems and prognosis of DAVM
DAVM are typically classified by location of the involved sinus or shunt as well as by the
pattern of venous drainage. [5] The pattern of venous drainage is a key factor predicting the
natural history of these lesions and provides the foundation for the widely adopted Borden [7]
and Cognard [8] classification systems. Borden type I DAVM are mostly benign lesions that
exhibit normal antegrade flow into a dural sinus. Type II lesions exhibit a degree of AV
shunting exceeding the capacity of antegrade outflow from the involved sinus resulting in
retrograde venous drainage into cortical veins. Type III lesions drain exclusively into cortical
veins or a trapped sinus segment (sinus thrombosis at both ends from high-flow venous
congestion). The Cognard classification is a modified version of the Djindjian classification and
identifies five types of DAVM based on the pattern of venous outflow. Briefly, type I lesions
exhibit normal antegrade flow into a dural sinus. Type II DAVM show retrograde venous
drainage into the adjacent sinus segments (type IIa), cortical veins (type IIb) or both (type IIa
+b). Types III and IV DAVM drain directly into cortical veins, either with (type IV) or without
(type III) venous ectasia. Type V DAVM are typically localized to the tentorium or dural
coverings of the posterior fossa and are further characterized by drainage inferiorly into spinal
perimedullary veins.
Both classification systems have been validated and appear to correlate well with the risk of
intracranial hemorrhage or non-hemorrhagic neurologic deficit (NHND). [9] Borden types II
and III DAVM are associated with a more aggressive natural history and when technically
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feasible are generally treated because of their increased risk of symptomatic presentation. In
a study that included 20 patients with Borden type II and III lesions, Duffau et al [10] found
that rebleeding within 2 weeks after the first hemorrhage occurred in as many as 35% of
patients and noted that rehemorrhage carried a worse prognosis than the initial hemorrhage.
The authors recommended complete and early treatment of ruptured DAVM with cortical
venous drainage (CVD). On the other hand, Borden type I DAVM generally have a benign
natural history. In a study where 68 patients with Borden Type I DAVM were conservatively
treated and followed for a mean of 27.9 months, Satomi and colleagues [11] found that only 1
patient suffered an intracranial hemorrhage and noted a benign and tolerable level of disease
in 98.5% of cases. However, according to a recent report, the risk of conversion of a Type I
lesion to a more aggressive lesion with CVD appears to be higher than previously reported
(annual rate of 1%). [12] Any change in patient symptoms should therefore prompt repeat
angiographic imaging to rule out the development of alternative drainage routes.
The annual risk of hemorrhage of DAVM varies between 1.8% and 15%. [13-14] The first
hemorrhagic episode of a DAVM is associated with >30% mortality or serious disability.
The annual mortality rate for DAVM with CVD may be as high as 10.4% with a combined
annual risk of intracranial hemorrhage and NHND of 15%. [15] Recent data suggest that the
natural history of DAVM dependents not only on the pattern of venous drainage, but also on
the mode of presentation. As such, Soderman et al [16] found that the annual hemorrhage risk
of Borden Type II or III DAVM was 7.4% for patients presenting with intracranial hemorrhage
compared with only 1.5% for those with non-hemorrhagic presentation. Likewise, in a study
by Strom et al [17] that included 28 patients with Borden Type II or III DAVM, the risks of
hemorrhage and NHND were 7.6% and 11.4% respectively for lesions with symptomatic CVD
versus only 1.4% and 0% for those with asymptomatic CVD. Based upon these data, Zipfel et
al [18] proposed the inclusion of the mode of presentation (symptomatic or asymptomatic
CVD) into the Borden and Cognard classification systems to allow for more accurate risk
stratification in patients with high-grade DAVM.
Type Borden Cognard
I Drains directly into venous sinus or
meningeal vein
Normal antegrade flow into dural sinus
II Drains into dural sinus or meningeal veins
with retrograde drainage into cortical veins
a) Retrograde flow into sinus(es)
b) Retrograde filling of cortical vein(s)
a+b) Retrograde drainage into sinus(es) and cortical
vein(s)
III Drains into cortical veins without dural sinus
or meningeal involvement
Direct drainage into cortical veins without venous
ectasia.
IV Direct drainage into cortical veins with venous ectasia
>5 mm and 3x larger than diameter of draining vein.
V Drainage to spinal perimedullary veins
Table 1. The Borden and Cognard classification systems of DAVM
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More recently, Geibprasert et al [19] have proposed an ambitious classification, conceptually
unifying pathophysiologic consequences of cranial and spinal DAVM on an embryologic basis.
The scheme is based on the venous afferent patterns of three epidural spaces: 1) the ventral
drainage group derived from the notochord and corresponding sclerotome extending from
the base of the sphenoid to the sacrum, 2) the dorsal epidural space derived primarily from
the dorsally located intracranial dural sinuses as this space is not well-developed in the spine,
and 3) the lateral epidural shunts located where lateral pial emissary bridging veins pierce the
dura. By examining 300 patients with DAVM and categorizing their lesions by their respective
afferent venous patterns, Geibprasert et al were able to establish some clinical generalizations
about each group. Ventral epidural shunts demonstrated a 2.3:1 female predominance and
were less likely associated with cortical venous reflux unless there was extensive thrombosis
of the epidural drainage or an especially high-flow shunt. Similarly, dorsal epidural shunts
were less likely to reflux into the cortical veins unless thrombosis was present. These lesions
did not demonstrate sex predominance but did tend to occur in a lower age group (pediatric)
and more frequently occur as multiple lesions. The lateral epidural shunts tended to present
in older patients and were more common in men. These lateral lesions were always clinically
aggressive and demonstrated significant cortical venous reflux.
2. Clinical features of DAVM and anatomic considerations for
embolization
The clinical features associated with DAVM generally depend on the location of the lesion, the
extent of the AV shunting, and associated abnormalities of venous drainage. [20-21] Symptoms
may be indistinguishable from those associated with pial brain arteriovenous malformations
and may include headache, diplopia, blurred vision, or neurologic dysfunction. Focal neuro‐
logic deficits and seizures may develop in relation to disturbances in regional cortical venous
drainage resulting from the redirection of venous flow from the shunt into pial veins, poten‐
tially congesting venous territory remote from the site of the dural fistula. In patients with
severe compromise of the deep venous drainage of the brain or with diffuse intracranial
hypertension resulting from the obstruction of both sigmoid sinuses, the clinical presentation
may include dementia. [5] Dementia may also develop in patients with superior sagittal sinus
DAVM due to venous congestion of bilateral frontal lobes. Closure of the arteriovenous shunts
may successfully reverse this state only when there are adequate residual venous channels
available for the normal venous drainage of the brain. Rarely, cranial neuropathy or unilateral
visual phenomena may arise secondary to arterial steal without evidence of associated venous
hypertension. [22] Focal symptomatology may worsen or change as a result of the redirection
of venous outflow from a DAVM. For example, progressive thrombosis and occlusion of the
inferior and superior petrosal sinuses may be associated with worsening of signs in a patient
with a cavernous sinus DAVM draining anteriorly through the ipsilateral ophthalmic veins.
If contralateral drainage is available, the venous sinus hypertension may be transmitted to the
contralateral cavernous sinus, leading to development of bilateral orbital symptoms.
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The signs and symptoms of increased intracranial pressure occasionally complicate cases of
DAVM. In certain cases this can be attributed to diminished CSF absorption through the
arachnoid villi resulting from the transmission of increased venous pressure throughout the
superior sagittal sinus. Patients may present with typical symptoms of normal pressure
hydrocephalus, such as progressive dementia, gait disturbance, and urinary incontinence. [23]
Alternatively, obstruction of the cerebral aqueduct secondary to compression of the mesence‐
phalon by an ectatic draining vein may occur, leading to obstructive hydrocephalus.
[24]Moreover, aneurysmal venous ectasia may unusually cause symptomatic mechanical
compression of adjacent neurologic structures, most commonly in DAVM draining into pial
veins of the posterior fossa. This is particularly true for type IV DAVM, which not infrequently
present with clinical symptoms related to mass effect caused by pronounced venous ectasia. [5]
Approximately 20 to 33 percent of patients with symptomatic DAVM present with an intra‐
cranial hemorrhage. This most frequently is encountered in lesions involving the floor of the
anterior cranial fossa or the tentorium cerebelli; however, it may occur in any case associated
with cortical venous drainage, particularly in the presence of significant cerebral venous
ectasia.2 In a recent large study by Bulters et al, [25] DAVM associated with venous ectasia had
a 7-fold increase in the incidence of hemorrhage (3.5% no ectasia vs 27% with ectasia).
Therefore, patients with venous ectasia may represent a high-risk group that requires rapid
intervention.
For those DAVM that present in ways other than hemorrhage, the clinical presentation
depends entirely on the grade, location and venous afferent pattern of the fistula. This allows
DAVM to be categorized clinicoanatomically into those involving the cavernous sinus,
transverse and sigmoid sinuses, superior sagittal sinus, petrosal sinus, torcular, tentorial
incisura, and anterior cranial base.
Approximately one-third to one-half of symptomatic intracranial DAVM involve the trans‐
verse and sigmoid sinuses. [26] Nearly half present with a subjective bruit as the first clinical
manifestation due to proximity of the draining sinus to the middle ear. The tinnitus is
synchronized to arterial pulsations and results from increased blood flow into the sigmoid or
transverse sinuses. Auscultation over the retroauricular area usually reveals the pulsatile bruit.
As with the other DAVM, additional neurologic symptoms and findings generally depend on
the pattern of venous drainage encountered in the individual patient. Symptoms may include
chronic signs of increased intracranial pressure potentially leading to papilledema and optic
atrophy in addition to disturbances related to balance and hearing. Aggressive neurologic
symptoms may occur in up to 27% of patients with transverse and sigmoid DAVM. In
progressive cases, associated with obstruction of the ipsilateral jugular outflow redirected
venous drainage into pial veins of the posterior fossa may result in brain stem or cerebellar
dysfunction as well as posterior fossa hemorrhage. Rerouting of drainage into the supraten‐
torial cortical venous compartment may be associated with the development of focal neuro‐
logic deficit or seizures as well as increased risk of intracranial hemorrhage. Spontaneous
occlusion of transverse and sigmoid DAVM is rare (5%) and generally occurs after hemorrhagic
events.
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DAVM involving the superior sagittal sinus, tentorial incisura, petrosal sinuses, and anterior
cranial base occur less frequently than DAVM involving the transverse, sigmoid, or cavernous
sinuses. [5, 27] In these lesions, symptoms typically depend on the route of abnormal venous
drainage and associated pattern of venous hypertension, and may include dysphasia, hemi‐
paresis, hemisensory deficits, and abnormal visual phenomena. Several specific features
deserve particular attention. (1) Dural fistulas involving the floor of the anterior cranial fossa
are usually associated with drainage into ectatic parasagittal cortical veins and often present
with intracranial hemorrhage. [27] Moreover, these patients may exhibit unilateral visual loss
secondary to arterial steal from the ophthalmic circulation into ethmoidal and recurrent
meningeal supplies to the shunt. Although a majority of these lesions are treated with open
surgery, embolization through the ophthalmic artery can be undertaken with a reasonably
high success rate and low complication risks. [28] (2) DAVM of the petrosal sinuses or tentorial
incisura may occasionally drain inferiorly into perimedullary veins of the spinal cord (type V),
resulting in progressive myelopathy similar to that encountered in spinal dural AVMs. [26]
Assuming the venous sinus drainage of the brain is otherwise unimpaired, these symptoms
usually respond well to endovascular or surgical closure of the shunt. Tentorial DAVM drain
only via the leptomeningeal-cortical venous system. Consequently, they behave aggressively
with severe hemorrhagic and nonhemorrhagic symptoms occurring in 19% and 10% of cases
per year. Also, it is not uncommon for such lesions to cause fatal bleeding in the posterior fossa.
Therefore, they should be treated aggressively by endovascular and/or surgical means to
disconnect the venous drainage system and minimize the risk of hemorrhage and NHND.
Superior sagittal sinus DAVM are frequently associated with restrictive change of the superior
sagittal sinus and retrograde CVD. Thus, aggressive neurologic symptoms are common and
occur in nearly one-half of cases. [29]
DAVM most frequently involve the transverse sinuses. Arterial supply to fistulae of this region
predictably derive from identifiable supratentorial and infratentorial sources. The supraten‐
torial group is usually organized around 1) contributors to the basal tentorial arcade, typically
including the petrosal and petrosquamosal divisions of the MMA and the lateral division of
the meningohypophyseal trunk off the ICA, and, occasionally 2) tranosseous branches of the
posterior auricular artery. The infratentorial group commonly involves the jugular division of
the ascending pharyngeal artery, transmastoid and more distal transosseous branches of the
occipital artery, and the posterior meningeal arteries and artery of the falx cerebelli, either of
which can variably arise from the occipital, vertebral or ascending pharyngeal arteries as well
as rarely directly from the PICA. With higher flow lesions indirect contribution from contrala‐
teral sources may be seen but this usually involves anastomosis with one of the above-
mentioned conduits as a final common pathway.
In terms of embolization hazards, the petrosal branch of MMA notably gives rise to a branch
which anastomoses with the stylomastoid branch of the occipital or posterior auricular arteries
forming an arterial arcade within the facial canal which if aggressively embolized (inadver‐
tently) may result in damage to the facial nerve. In that the petrosal branch of the MMA usually
participates in the supply of transverse sinus DAVM through the basal tentorial arcade, its
contribution to the lesion commonly can be indirectly devascularized by accessing the basal
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tentorial arcade posterolaterally through the petrosquamosal division of the MMA avoiding
the need for direct catheterization and embolization of the petrosal branch altogether. The
basal tentorial arcade is an arterial network extending along the insertion of the tentorium into
the petrous ridge from the petroclinoid ligament laterally to the transverse sinus. The jugular
division of the APA enters the cranial vault via the jugular foramen supplying CN 9,10,11
before dividing into medial and lateral divisions. The medial division courses along the inferior
petrosal sinus where it supplies CN 6 and anastomoses with the medial division of the lateral
clival branch of MHT. The lateral division runs superiorly along the sigmoid sinus and
vascularizes the dura along the transverse sigmoidal confluence. In very high flow fistulae of
the distal transverse sinus or lesions of the sigmoid sinus and foramen magnum, recruitment
of supply through the hypoglossal division of the ascending pharyngeal artery may be seen
(particularly where this artery gives rise to the ipsilateral posterior meningeal artery. Trans‐
arterial embolizations through this division of the APA (particularly with liquid embolic
agents) may result in injury to CN 12 leading to ipsilateral paresis of the tongue.
DAVM of the cavernous sinus (CSDAVM) are most commonly seen in female patients and
generally associated with orbital signs and symptoms that fluctuate depending on alterations
in orbital venous outflow, which develop secondary to thrombosis and changes in head
position. Patients typically present with the gradual onset of focal or diffuse chronic eye
redness distinguishable from uveitis. Close inspection reveals dilated tortuous conjunctival
and epibulbar vessels that exhibit an acute angulation near the ocular limbus. [30-31] These
lesions are often associated with an elevation of episcleral venous pressure leading to a
persistent rise in intraocular pressure in the affected eye, potentially resulting in the develop‐
ment of glaucoma. If both cavernous sinuses become involved in the venous drainage
secondary to a change in the ipsilateral venous outflow of the affected cavernous sinus, the
ocular findings may become bilateral. The patient may complain of pulsatile tinnitus, and in
25 percent of cases a bruit can be auscultated over the orbit. [5] Cranial neuropathies, most
commonly involving the sixth nerve, frequently lead to ocular motor dysfunction, which also
may be exacerbated by orbital venous congestion and proptosis. More important to the
planning of embolization are the hypoxic ischemic retinal changes that develop in approxi‐
mately 15 percent of patients. [21] Rarely, if thrombosis in the cavernous sinus is extensive,
abnormal drainage into cerebral veins may occur, increasing the likelihood of an intracranial
hemorrhage or venous infarction. [5] Unfortunately, frequently cited classification schemes of
intracranial DAVM are deficient in their handling of CSDAVM due to the lack of explicit
consideration given to ophthalmic venous drainage and the clinical consequences of orbital
venous congestion. Despite the lack of a coherent classification scheme for CSDAVM, the
implications of venous outflow from these lesions are similar to DAVM at other locations and
the analysis of venous drainage is important in understanding the pathophysiology of the
disease at this site. An excellent study of the clinical manifestations in 85 patients with
CSDAVM relative to their angiographic characteristics was reported by Stiebel-Kalish et al.
[32-33] In this study, the clinical symptoms found in patients with CSDAVM were related to
the abnormal venous drainage and could be predicted by analysis of the aberrant venous
drainage patterns. Interestingly, central nervous system symptoms or dysfunction, were found
in 7 (8%) of these patients, attesting to the potential danger of cortical venous drainage even
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among patients with CSDAVM. Spontaneous regression of CSDAVM is a well-described
phenomenon that is observed in 10%–50% of cases. [29]
The vascular supply to the dura of the cavernous sinus is complex because of extensive regional
anastomoses between dural branches of the internal carotid and branches of the internal
maxillary artery (middle meningeal, and accessory meningeal arteries, and the artery of the
foramen rotundum). Moreover, the ophthalmic artery may participate indirectly via a tentorial
branch of the recurrent meningeal artery. From the perspective of angiographic workup and
embolization, these lesions may be divided conceptually into two groups: (1) an anterolateral
group, arising from the orbital apex and lateral cavernous sinus, and (2) a posterior group,
including the posterior cavernous sinus, petroclinoid ligament, and dorsum sella.
The meningeal supply to anterior division lesions may be considered to reflect the hemody‐
namic balance between branches arising from the horizontal segment of the cavernous internal
carotid artery, most notably the inferolateral trunk (ILT) and meningeal branches of the
internal maxillary artery. This latter group includes cavernous and recurrent tentorial branches
of the MMA, cavernous meningeal branches of the accessory meningeal artery, and the artery
of the foramen rotundum. As expected, embolization of these meningeal arteries should be
preceded by superselective angiographic analysis to prevent inadvertent embolization into the
internal carotid artery or possible damage to the orbit or regional cranial nerves.
The supply to posterior division lesions is derived primarily from medial and lateral clival
(meningohypophyseal) branches of the internal carotid artery and their potential anastomotic
connections with branches of the ascending pharyngeal and middle meningeal arteries. These
most notably include the ascending clival and inferior petrosal arcades, derived from the
hypoglossal and jugular divisions of the ascending pharyngeal artery, respectively; the
posterior cavernous branches of the MMA; and the basal tentorial arcade supplied by the
petrosal and the petrosquamosal branches of the MMA.
Three critical points should be considered before embolization of fistulae involving this
territory. (1) The vascular supply to the intrapetrous facial nerve should be determined. This
may arise primarily from the petrous branch of the MMA. For this reason, petroclinoid lesions
supplied by the basal tentorial arcade should be embolized preferentially from the petrosqua‐
mosal branch of the MMA, thereby avoiding the proximal petrosal artery. (2) Potential
contributions from the contralateral internal carotid and ascending pharyngeal arteries via
transclival anastomoses should be evaluated, particularly in lesions involving the dorsum
sellae. (3) Because embolization of upper clival and petroclinoid lesions may involve the
hypoglossal or jugular division of the ascending pharyngeal artery, attention must be directed
to the possibility of iatrogenic lower cranial neuropathy when using NBCA, Onyx, or ethanol.
Midline lesions requiring aggressive embolization of pedicles from both ascending pharyngeal
arteries should be performed as a staged procedure on different days, specifically to avoid
development of bilateral hypoglossal nerve deficits.
The simplest and most commonly utilized route to access the cavernous sinus is through the
inferior petrosal sinus. Guidewire or microcatheter navigation through the sinus may be
complicated by vessel rupture. Alternatively, access to the cavernous sinus may be obtained
Endovascular Management of Dural Arteriovenous Malformations
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through the facial vein or the superficial temporal vein. Direct operative cannulation of the
superior ophthalmic vein is also an acceptable route to the cavernous sinus when other
approaches have been exhausted. [34]
3. Imaging of DAVM
Recent advances in both computed tomography (CT) and magnetic resonance imaging (MRI)
have significantly contributed to the initial diagnostic evaluation of patients with suspected
DAVM. Because CT and MRI findings are nonspecific, however, the diagnosis can be delayed
or missed. Routine conventional head CT is the first-line investigation of patients presenting
with tinnitus, headache or other neurological symptoms. Its value is limited to identifying
intracranial hemorrhage and edema due to venous congestion (area of low density). Focal or
generalized atrophy of the brain, possibly accompanied by hydrocephalus, are nonspecific
secondary findings that may be appreciated. Although not infrequently diagnostically
equivocal, MRI is more helpful than CT because it can reveal dilated vessels, thrombosed
venous structures, and prominent vascular enhancement particularly in patients with DAVM
associated with CVD. The combination of prominent flow voids on the cortical surface and
high-intensity lesions in the deep white matter on T2-weighted images secondary to venous
hypertension/congestion is highly suggestive of a DAVM. Despite the presence of these
secondary signs that suggest the presence of a DAVM, conventional MRI alone is generally
unsuccessful in defining the exact site of fistulization. Any suspicious findings on CT/MRI
should prompt catheter angiographic evaluation.
The advent of CT angiography (CTA) and magnetic resonance angiography (MRA) has
provided more power to the noninvasive screening of patients with suspected DAVM. In
addition to providing anatomic details, these modalities may be coupled with perfusion
studies to evaluate the effect of a DAVM on regional blood flow.
CTA aids in the accurate diagnosis and characterization of DAVM by localizing the fistula and
demonstrating the pattern of venous drainage and supplying arteries. Overlapping bone
structures may make it difficult to demonstrate the detailed vascular pattern of DAVM
especially for smaller lesions. The sensitivity of CTA for diagnosis of DAVM is reportedly
lower than the sensitivity of MRA (15.4% versus 50%). [35] Lee et al [36] recently introduced
a CTA algorithm for bone removal (hybrid CTA) that eliminates bone structures while
preserving enhancing transosseous vascular structures. They found that the technique
provides valuable information for treatment planning and carries a sensitivity of 93% and a
specificity of 98%. In addition, recent studies have shown that 4D CTA with high spatial and
temporal resolution are suitable for the diagnosis, classification, treatment planning, and
follow-up imaging of DAVM. [37-38]
MRA may be performed using a three-dimensional time-of-flight (3D TOF) technique or MR
digital subtraction angiography (MR DSA). [39-42] The presence of multiple high-intensity
curvilinear or nodular structures adjacent to a sinus, in conjunction with high-intensity foci
within the sinus is considered suspicious for a DAVM; however, the technique still suffers
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from a high false positive rate, with as many as 14% of otherwise healthy patients incorrectly
identified as possibly harboring a DAVM by 3D TOF MRA. Although the current spatial
resolution of MR DSA is less than 3D TOF MRA, the benefit of MR DSA would be related to
the temporal resolution of the technique and the ability to depict flow within cortical veins,
particularly important in those patients with retrograde flow from a DAVM.
Despite the advances in both CTA and MRA, conventional digital subtraction angiography
remains paramount in the diagnosis and pretreatment evaluation of intracranial DAVM.
The angiographic evaluation usually includes selective studies of the internal and external
carotid arteries bilaterally as well as of both vertebral arteries when evaluating lesions of the
posterior fossa or tentorium. The pretherapeutic examination must be tailored to the clinically
suspected location of the fistula and must disclose the entire arterial supply, as well as any
anastomoses between the supplying vessels and arterial distributions to the orbit, brain, or
cranial nerves. This usually requires superselective arterial catheterization and angiography
before the use of embolic materials. The venous anatomy must be studied with respect to the
pattern of drainage from the fistula, and the adequacy of normal venous drainage of the brain
must be assessed.
4. Therapeutic approaches to DAVM
Because many DAVM regress spontaneously or remain asymptomatic throughout the
patient’s life, it is crucial to weigh the risks of treatment against the natural history of these
lesions. Management should be tailored to the type of lesion (location, classification, and
angiographic features) and individual patient history (age, clinical presentation, and comor‐
bidities) and may include relief of symptoms or complete occlusion of the DAVM. Although
spontaneous resolution of clinical signs related to DAVM is not uncommon, most symptomatic
lesions require some form of treatment. Treatment options include observation, carotid-jugular
compression, transarterial embolization, transvenous embolization, open surgery and
stereotactic radiosurgery. In the majority of patients, a multimodality approach with a
combination of treatment offers the best chance for success.
Patients with Type I DAVM are at low risk of hemorrhage and should be managed conserva‐
tively unless they have disabling clinical symptoms like tinnitus or develop new neurological
deficits or CVD at follow-up. Expectant follow-up of asymptomatic lesions should include
serial MRI to detect changes in the DAVM anatomy. Angiographic follow-up should also be
considered every few years especially for DAVM of the anterior cranial fossa or the tentorial
incisura, which commonly develop CVD. Patients with symptomatic type II or III DAVM
should be treated aggressively to minimize the risk of hemorrhage and NHND. The manage‐
ment of asymptomatic type II and III lesions should take into consideration the patient’s age,
treatment decision and risk of future hemorrhage. Intervention is often favored over obser‐
vation because of the long-term risk to the patient and the dismal natural history of an
intracranial hemorrhage.
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Carotid-Jugular Compression. Patients with Borden type I transverse or sigmoid sinus DAVM
or with fistulas of the cavernous sinus and otherwise normal ophthalmologic examinations
may be treated conservatively with ipsilateral carotid or occipital artery compression. Inter‐
mittent manual compression of the carotid artery may be effective in eliminating DAVM
involving the ipsilateral cavernous sinus in patients with mild findings and no evidence of
carotid vascular disease or other contraindications to carotid compression. [21] The ipsilateral
carotid artery is compressed, using the contralateral hand, for approximately 5 minutes every
waking hour for 1 to 3 days. If this is tolerated, the compression time is increased to 10 to 15
minutes of compression per waking hour. The compression, if properly performed, produces
concomitant partial obstruction of the ipsilateral carotid artery and jugular vein. This results
in the transient reduction of arteriovenous shunting by decreasing arterial inflow while
simultaneously increasing the outlet venous pressure, thereby promoting spontaneous
thrombosis within the nidus. Nearly 30% of cavernous sinus and 25% of transverse/sigmoid
sinus DAVM will thrombose with compression therapy. [43-44] Compression therapy is
usually not recommended in patients with CVD.
Embolization. The development of improved superselective angiographic catheter systems
and embolic agents has increased the role of interventional neuroradiology in the management
of these lesions, both primarily and preoperatively. Two strategies, transvenous and transar‐
terial have been employed and their appropriate selection depends on the location and
complexity of the DAVM, its vascular features and the potential complications inherent to each
technique. Treatment aims to completely occlude the arteriovenous fistula. If this is not an
option, selective disconnection of the CVD is an acceptable option that is equally effective in
reducing the risk of hemorrhage and NHND associated with DAVM. [45]
Transvenous embolization with metallic coils or detachable balloons has been advocated
primarily for the treatment of DAVM involving the transverse, sigmoid or cavernous sinuses.
The technique involves a transfemoral or intraoperative approach to the affected venous sinus
following which coils, balloons or liquid embolic agents are deposited adjacent to the shunt.
Several features are critical in appropriate patient selection for this method of treatment. (1)
The segment of sinus to be occluded must be in proximity to the fistula and receive its entire
venous drainage. (2) The sinus to be occluded should not be essential to the normal venous
drainage of the brain. The cerebral venous drainage must be thoroughly evaluated before
embolization to determine the alternate pathways for cerebral venous outflow and avoid
potential venous infarction or hemorrhage. (3) The target sinus must be completely occluded
throughout the involved segment to avoid diversion of fistulous flow into confluent cerebral
veins and worsening of CVD. Such redirection of a high flow shunt into previously uninvolved
low capacitance venous channels may precipitate an acute venous infarct or hemorrhage.
Levrier et al developed a novel way to treat DAVM that would preserve the venous sinus. [46]
In ten patients including fistulas grade I-IV both with and without sinus stenosis, the re‐
searchers used a transvenous approach to angioplasty the involved sinus and then placed
stents with high radial force to bridge the ostia of cortical veins draining into the sinus. Their
follow-up at 7 months by conventional angiography revealed that four patients had complete
DAVM occlusion and four had significantly reduced flow through the fistula. Two subjects
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refused repeat angiography. At two years, CTA confirmed stent patency in eight out of nine
patients imaged. The safety and long-term efficacy of this technique, however, require further
investigation.
Transvenous embolization is particularly useful for DAVM with multiple arterial feeders.
Typically, involved arteries are small and torturous arterial feeders, which renders selective
catheterization extremely challenging or hazardous. Ease of access to the fistulous site and the
ability to obliterate the fistula in a single session are important advantages of this approach.
Transvenous embolization is associated with a low complication rate and high rates of cure
and complete occlusion of the fistula. [47-48] Transvenous embolization, however, is less suited
for DAVM involving the superior sagittal sinus. It can also be associated with severe compli‐
cations, including vessel rupture, sinus venous thrombosis, venous infarction, hemorrhage,
and neurological deficits related to disruption of venous drainage. [49] Hemorrhage may be
related to vessel injury or to the sacrifice of a dural sinus draining normal brain parenchyma.
Additionally, transvenous embolization is rarely associated with the development of de novo
DAVM at secondary intracranial sites following occlusion of the primary lesion. While the
etiology of these secondary de novo fistulas is unclear, they may arise from angiogenesis
induced by venous hypertension secondary to the occlusion of the major dural sinuses targeted
by transvenous embolization.
Under some circumstances, transarterial embolization with liquid embolic agents offers
advantages over a transvenous approach. Not infrequently, transvenous access to the DAVM
is limited by venous sinus occlusion or high-grade stenoses preventing transvenous catheter‐
ization. Likewise, high-grade lesions emptying directly into remote small cerebral veins may
be inaccessible to uncomplicated venous catheterization. As such, tentorial incisura and
anterior cranial fossa DAVM, which frequently behave aggressively, may not be accessed
transvenously. Transarterial delivery of a liquid embolic agent capable of permeating the
vascular apparatus of the shunt provides the means for discrete definitive occlusion of the
fistula site and reduces the likelihood for diversion of shunt flow into more dangerous alternate
venous pathways while enabling closure of the fistula without necessarily sacrificing an entire
venous conduit that may be critical to the drainage of normal brain parenchyma. Conversely,
incomplete occlusion of the fistula by transarterial embolization is usually complicated by
recruitment of new collateral vessels that are smaller, more tortuous and less amenable to
embolization. Complex fistulas may require a multistaged approach combining transarterial
and transvenous techniques to eliminate CVD and occlude the fistula.
Transarterial embolization may be effective in palliating disabling symptoms through
occlusion of arterial feeders even without angiographic cure of the DAVM. Transarterial
embolization also plays an important role in decreasing flow through DAVM before surgical
intervention, transvenous obliteration, and radiosurgery. [50-51]
The transarterial approach requires selective catheterization of individual feeding vessels
followed by superselective angiography to evaluate the vascular supply to the fistula,
particularly with respect to potential anastomoses with the orbit or cerebral vasculature. It is
important to understand that such anastomoses may not be demonstrable on the initial
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angiograms but may become manifest as progressive embolization produces alterations in
flow within the target vascular territory.
Guidewire-directed microcatheters are typically employed in the catheterization of meningeal
branches supplying such lesions. The embolic agents commonly used in transarterial emboliza‐
tion of DAVM are liquid cyanoacrylate (NBCA), Onyx, polyvinyl alcohol foam (PVA), or ethanol.
Ideally, liquid embolic agents, delivered close to the shunt under wedged-microcatheter induced
flow arrest, present the best opportunity for embolotherapeutic cure of the lesion as it enables
permeation of the collateral complex supplying the fistula and its immediate venous receptacle
thus permanently occluding the shunt. Such a degree of permeation is not possible using
particulate agents that characteristically lodge within arterioles of the peri-fistula microcollater‐
al network at a point proximal to the shunt. If not fully permeated, these microcollateral net‐
works will then evolve and reestablish flow through the shunt complex.
Also, the particles degrade within days to weeks, resulting in high recurrence rates of the fistula
and possibly in extensive shunting into leptomeningeal veins. Transarterial embolization with
PVA is therefore used to relieve symptoms or in combination with other procedures such as
radiation, surgery, or transvenous embolization. As with PVA, embolization with coils alone
does not provide complete obliteration of DAVM. [52]
Nevertheless, PVA may find use in several situations. First, the initial use of PVA in embolizing
the less favorable arterial supplies to a multi-pedicle fistula, may facilitate more complete
subsequent embolization of the shunt with liquid embolic agents through a safer conduit. The
embolization of competing inflows to the shunt with PVA allows the undiluted permeation of
the fistula by the liquid embolic agent without fragmentation of the glue column. PVA may
also be useful in reducing flow through low-velocity shunts, thereby facilitating thrombosis
in these DAVM. This can be particularly applicable in managing low flow CSDAVM, and may
be combined with manual compression in treating lesions also supplied by cavernous segment
dural branches of the ipsilateral ICA.
In certain situations, partial embolization of dural fistulas may be performed in an attempt to
alleviate disabling symptoms. For example, partial embolization of a cavernous sinus DAVM can
reduce intraocular pressure in a patient suffering acute deterioration of visual acuity. Aggres‐
sive treatment in such cases may not be needed unless symptoms are particularly disabling or the
DAVM is associated with CVD. Partial embolization may also be advocated in patients present‐
ing with new-onset dementia or in those patients with severe tinnitus. Lastly, PVA and liquid
embolic agents are used in the preoperative devascularization of dural fistulas prior to surgical
excision. In this situation, particulate embolic agents, because of their low morbidity, are generally
preferred and should be applied 1 to 2 days before surgery.
NBCA has been widely utilized for transarterial embolization of DAVM with fairly good results.
Guedin et al [53] treated 43 patients with Borden Type II or III DAVM using NBCA and reported
complete obliteration of the fistula in 34 patients (79%) and occlusion of CVD in all remaining
cases. There was no treatment-related mortality or permanent morbidity in the series. Interesting‐
ly, they reported post-embolization secondary thrombosis in 5 patients in whom residual flow
was noted on the immediate post-treatment angiograms. In a recent large study by Kim et al [54]
that included 121 DAVM treated with transarterial glue embolization, immediate cure was
achieved in 14.0% of lesions, and progressive complete thrombosis of the residual shunt at follow-
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up in 15.7% of lesions. Surgical CVD disconnection or transvenous coil embolization was
necessary for clinically important residual shunts in as many as 45.2% of all cases. Procedural
complications were seen in 7.8% of patients in the series.
However, use of NBCA has some disadvantages. It is an adhesive agent that undergoes rapid
polymerization at contact with blood, which may increase the risk of microcatheter retention or
avulsion of the feeding artery upon removal of the microcatheter. The injection must be per‐
formed quickly and continuously, which may diminish the precision of injection and result in
suboptimal penetration into the fistulous site. Use of a wedged microcatheter technique with low-









Figure 1. Frontal (A) and lateral (B, C) views of digital subtraction angiography (DSA) in a 50-year-old woman who
sustained an intraventricular hemorrhage showing a DAVM fed by posterior branches of the pericallosal artery and
draining into the straight sinus. Frontal (D) and lateral (E) views of DSA following embolization with 0.4 mL of NBCA
40% showing complete occlusion of the fistula. Frontal (F) and lateral (G) views of follow-up DSA 7 months later
showing durable occlusion of the DAVM.
Recently, the introduction of Onyx has added an important element to the endovascular
armamentarium and improved the endovascular treatment of DAVM. Onyx is comprised of
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ethylene vinyl alcohol copolymer dissolved in DMSO (dimethyl sulfoxide), and suspended
micronized tantalum powder to provide contrast for visualization under fluoroscopy. Onyx
offers several advantages over NBCA, which allow for safer and more efficient treatment of
DAVM. Due to its lava-like flow pattern and its nonadhesive nature, Onyx facilitates longer,
slower, and more controlled injections with better penetration of the fistula. It also allows
embolization of a substantial portion of the lesion from a single pedicle injection because the
agent can efficiently penetrate the depths of the fistulous connection and then flow into
adjacent arterial feeders, thereby obviating the need for multiple embolizations. The interven‐
tionalist can even discontinue Onyx injection for angiographic assessment of the embolization
and evaluation of collateral and en passage feeders that may become evident during the course
of embolization. Additionally, Onyx is less adherent to the microcatheter than NBCA with
possibly a lower risk of catheter retention and arterial rupture. The middle meningeal artery
provides an excellent route for Onyx injection with particularly high curative rates according
to several reports. [55-57] The middle meningeal artery is easy to catheterize and its branches
are anchored to the dura and calvarium, which facilitates removal of the microcatheter and
minimizes the risk of arterial avulsion.
Onyx has some disadvantages compared to NBCA, namely an increase in fluoroscopy time,
procedure time, and procedure cost. Cranial nerve injury and DMSO-induced angiotoxicity
are additional disadvantages of Onyx. There is also a risk of distal embolization of the embolic
material into the venous system and the pulmonary circulation.
Several investigators have reported remarkably high cure rates with this embolic agent, with a
high proportion of treatments completed in a single session. [49] Cognard et al enrolled 30 patients
in a prospective trial: ten were graded type II, eight type III and twelve type IV fistulas. [55] They
reported complete anatomic cure in 24/30 patients with only two complications, including a
temporary cranial nerve palsy and post-procedure hemorrhage secondary to venous outlet
thrombosis. Lv et al report their experience with 40 patients suffering from DAVM. [27, 58] They
report a complete occlusion rate of 25/40 or 62.3%. Nine patients suffered complications includ‐
ing reflexive bradyarrhythmia in 3 patients, hemifacial hypoesthesia in 3, hemifacial palsy in 2,
posterior infarction in 2, jaw pain in 1, hallucinations in 1, Onyx migration in 1 and retention of a
microcatheter tip in 1. Abud et al [59] treated 44 DAVM with Onyx and achieved occlusion of the
shunt in all but 9 patients, 5 of whom were successfully treated by complimentary transvenous
embolization with coils and Onyx. In as many as 81% of cases, a cure was obtained in a single
session. Six complications were observed including 4 cranial nerve injuries and 2 cases of venous
thrombosis post-embolization. In a series of 29 DAVM treated with Onyx embolization, mostly
through a transarterial approach, Stiefel et al [56] achieved an angiographic cure in 72% of all
lesions, with complications occurring in 9.7% of cases and leading into permanent morbidity in
only 2.4%. We have recently reviewed our experience in 39 patients with DAVM treated be‐
tween 2001 and 2009 at Jefferson Hospital for Neuroscience. We found no major procedure-
related complications in the series and achieved an obliteration rate of 75% with elimination of
CVD in up to 85% of patients with Onyx embolization (Figure 2-3).






Figure 2. Frontal (A) and lateral (B) views of digital subtraction angiography (DSA) in a 66-year-old woman who sus‐
tained a subarachnoid hemorrhage showing an ethmoidal DAVM, fed by the ophthalmic artery and anterior ethmoi‐
dal branches, as well as an orbito-frontal branch of the anterior cerebral artery. A small 1 mm aneurysm is seen on the
orbito-frontal feeding vessel. The DAVM demonstrates CVD with a draining vein entering the anterior 1/3 of the supe‐
rior sagittal sinus. (C) Superselective injection through the orbito-frontal pedicle showing the aneurysm and the fistu‐
la. The aneurysm and the fistula were embolized with 0.1 ml of Onyx through the orbito-frontal pedicle. Frontal (D)
and lateral (E) views of DSA after embolization showing obliteration of the aneurysm and the fistula.
A few investigators have used Onyx in a transvenous approach to carotid-cavernous fistulas.
After an unsuccessful embolization of a C-C fistula using detachable coils and liquid adhesion
agents, Arat et al successfully completed the embolization by injecting Onyx into the cavernous
sinus forming a cast of the structure. [60-61] Similarly, He et al report their experience in 6
patients using a combination of detachable coils and Onyx via a transvenous approach. [62]
Four of the six cases were completely embolized in one attempt, whereas the other two required
staged procedures. In these latter two cases the patient suffered minor transient cranial nerve
palsies. Suzuki et al report equally good results in three patients with spontaneous C-C fistulas.
[63] In all these studies patients experienced rapid relief of their neuro-ophthalmologic
symptoms. El Hammady et al [64] treated 12 patients with C-C fistulas using Onyx, 8 through
a transvenous route and 4 through a transarterial route. All lesions in their series were
obliterated in a single session with resolution of presenting symptoms in 100% of patients by
2 months. Cranial neuropathies, however, were noted in 3 patients likely from post-emboli‐
zation cavernous sinus thrombosis and swelling or from cranial nerve ischemia/infarction from
deep penetration of Onyx. We have recently reported on Onyx embolization of C-C fistulas
through a surgical cannulation of the superior ophthalmic vein in a series of 10 patients. [34]
We achieved complete obliteration of the fistula in 8 patients and a significant reduction in
fistulous flow in 2 patients, with no procedural complications.
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5. The role of surgery
With the advent of Onyx, most lesions can now be successfully managed with endovascular
therapy. However, surgical treatment of DAVM may still be necessary when endovascular
options have failed. Surgery consists of disconnection of draining veins, disconnection of
arterial feeders, resection/packing of the dural sinus, and/or direct puncture and embolization
of large varices or meningeal arteries. Hoh et al [65] described a technique whereby the
draining vein is clipped close to the fistula with extensive dural coagulation.
DAVM of the anterior cranial fossa and the superior sagittal sinus are more suitable for surgical
treatment than other types of DAVM. Transarterial embolization plays an important role in




Figure 3. Lateral views of left common carotid artery (A) and left external carotid artery (B) injections of DSA in a 65-
year-old woman with severe disabling tinnitus showing a tentorial DAVM draining into the transverse-sigmoid junc‐
tion with no evidence of CVD. Feeding vessels arise from the superficial temporal artery, middle meningeal artery,
occipital artery, and posterior auricular artery. The fistula was treated by embolization with Onyx and PVA through the
left occipital artery, left middle meningeal branches, left posterior auricular artery, and superficial temporal arteries.
Frontal (C) and lateral (D) views of DSA after embolization showing significant reduction in flow through the fistula.
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exposure of the involved segment of the dural sinuses, thus affecting the quality and com‐
pleteness of surgical excision.
6. The role of stereotactic radiosurgery
Stereotactic radiosurgery is an acceptable option for DAVM not amenable to surgical or
endovascular therapies. It is best suited for benign lesions without CVD (type I) and for low-
flow cavernous DAVM (which typically do not have CVD). Radiosurgery induces thrombo‐
genic obliteration of DAVM with a latency period of up to two years. This treatment modality
is therefore not suitable for DAVM with CVD because such lesions have a malignant natural
history and require rapid and definitive treatment via surgical or endovascular means. A recent
review of 14 studies found that stereotactic radiosurgery with or without adjunctive emboli‐
zation results in DAVM obliteration in 71% of cases and post-treatment hemorrhage in 1.6%
of cases (4.8% of lesions with CVD). [66] Despite these promising results, experience with
radiosurgery in DAVM treatment remains limited and the efficacy of the technique requires
more investigation in large prospective studies. Meanwhile, stereotactic radiosurgery should
be reserved for lesions that are not amenable to surgical or endovascular interventions.
7. Conclusion
Recent advances in endovascular therapies and studies of the anatomical and functional
properties of DAVM led to a rapid evolution in their diagnosis and management. Onyx
embolization through transarterial or transvenous approaches has emerged as safe and highly
efficient treatment for even the most complex lesions. However, the decision of which
approach and embolic agent to use for treatment of a DAVM must be tailored to each indi‐
vidual case, recognizing that the most effective approach for permanent DAVM treatment,
particularly in high-flow shunts, may require a combination of approaches and embolic agents.
Treatment of DAVM should be entrusted to a multidisciplinary team with ample expertise in
the management of these often challenging lesions.
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